Description

UPRISE D3 60K (1X8 CAPS)

Indications

UPRISE D3 60K is primarily indicated for the prevention and treatment of vitamin D deficiency and insufficiency. Vitamin D plays a crucial role in maintaining bone health by facilitating calcium absorption in the gut, which is essential for normal bone mineralization. This product is particularly beneficial for individuals at risk of vitamin D deficiency, including the elderly, those with limited sun exposure, individuals with malabsorption syndromes, and patients with certain chronic diseases.

Mechanism of Action

The active ingredient in UPRISE D3 60K is cholecalciferol, a form of vitamin D3. Once ingested, cholecalciferol is converted in the liver to 25-hydroxyvitamin D, which is then further metabolized in the kidneys to its active form, calcitriol (1,25-dihydroxyvitamin D). Calcitriol exerts its effects by binding to vitamin D receptors in various tissues, leading to increased intestinal absorption of calcium and phosphate, enhanced bone mineralization, and modulation of immune function. This multifaceted action contributes to the maintenance of healthy bones and overall metabolic health.

Pharmacological Properties

UPRISE D3 60K is characterized by its high potency, delivering 60,000 IU of vitamin D3 per capsule. This formulation allows for convenient dosing, particularly for patients requiring high doses for therapeutic purposes. The pharmacokinetics of vitamin D3 indicate a relatively long half-life, allowing for less frequent dosing while maintaining adequate serum levels of 25-hydroxyvitamin D. The bioavailability of cholecalciferol is generally high when taken orally, and it is well-absorbed in the presence of dietary fats.

Contraindications

UPRISE D3 60K should not be used in individuals with known hypersensitivity to vitamin D or any of the excipients in the formulation. It is also contraindicated in patients with hypercalcemia, hyperphosphatemia, or vitamin D toxicity. Caution should be exercised in patients with conditions that may predispose them to hypercalcemia, such as sarcoidosis or certain malignancies. Prior to initiation, a thorough assessment of the patient’s medical history is recommended to identify any contraindications.

Side Effects

While UPRISE D3 60K is generally well-tolerated, some patients may experience side effects, particularly at high doses. Common side effects include gastrointestinal disturbances such as nausea, vomiting, constipation, and abdominal discomfort. More serious adverse effects may include hypercalcemia, which can manifest as weakness, confusion, and renal complications. Patients should be monitored for signs of vitamin D toxicity, especially during prolonged therapy or high-dose regimens.

Dosage and Administration

The recommended dosage of UPRISE D3 60K is typically one capsule taken once weekly or as directed by a healthcare professional. This dosing schedule is designed to maintain adequate serum levels of vitamin D while minimizing the risk of toxicity. It is advisable to take the capsule with a meal containing fat to enhance absorption. Patients should follow their healthcare provider’s instructions regarding duration of therapy and any necessary monitoring of serum vitamin D levels.

Interactions

UPRISE D3 60K may interact with certain medications and substances. For example, anticonvulsants such as phenytoin and phenobarbital may reduce the effectiveness of vitamin D by increasing its metabolism. Additionally, corticosteroids can inhibit the conversion of vitamin D to its active form, potentially leading to decreased calcium absorption. Patients taking thiazide diuretics should be monitored for hypercalcemia, as these medications can increase calcium levels. It is essential for patients to inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.

Precautions

Before starting UPRISE D3 60K, patients should undergo a thorough evaluation to assess their vitamin D status and identify any underlying conditions that may affect treatment. Regular monitoring of serum calcium and phosphate levels is recommended, especially in those receiving high doses or with risk factors for hypercalcemia. Patients with renal impairment should use caution, as their ability to metabolize vitamin D may be compromised. It is also advisable for pregnant or breastfeeding women to consult their healthcare provider before using this supplement.

Clinical Studies

Clinical studies have demonstrated the efficacy of vitamin D supplementation in improving bone health and reducing the risk of fractures in populations at risk for deficiency. A systematic review published in the Journal of Clinical Endocrinology & Metabolism indicated that high-dose vitamin D supplementation significantly increased serum 25-hydroxyvitamin D levels and improved bone mineral density in older adults. Another study highlighted the role of vitamin D in enhancing muscle strength and reducing the risk of falls in elderly patients. These findings support the use of UPRISE D3 60K as an effective intervention for managing vitamin D deficiency and its associated health risks.

Conclusion

UPRISE D3 60K serves as a potent and effective solution for addressing vitamin D deficiency and insufficiency. With its convenient dosing and proven efficacy, it is an essential supplement for individuals at risk of inadequate vitamin D levels. As with any supplement, it is crucial for patients to use UPRISE D3 60K responsibly and under the guidance of a healthcare professional to ensure optimal health outcomes.